Article
Author(s):
CURE® took a look at the most popular and practice-changing breast cancer news from 2022. Here’s what we found.
2022 was a landmark year in the breast cancer space — from the establishment of a new breast cancer subtype to novel methods to treat mastectomy-related pain.
CURE® looked back at the most popular and groundbreaking breast cancer articles from the year. They were:
1. New Way to Define Breast Cancer Opens Doors to Treat Previously-
In August, the Food and Drug Administration (FDA) approved Enhertu (fam-trastuzumab deruxtecan-nxki) for the treatment of patients with HER2-low breast cancer, a new subtype of the disease that allows for even better personalized treatment for patients with the disease. A feature story from CURE®’s Breast Cancer Special Issue highlights patients with HER2-low breast cancer and the clinicians who are treating them.
There is often a delay between breast cancer surgery and reconstruction, and a lack of data about whether this could impact recurrence rates. However, recent research published in the journal, Cancer, found that there was a similar risk of disease recurrence between patients who waited to undergo reconstruction and those who immediately received the surgery.
Some patients with breast cancer may be at risk for breast angiosarcoma, a rare type of secondary breast cancer that can come years after the initial diagnosis and radiation treatment. Treating this type of disease has historically been difficult, one expert explained, though there are new approaches that may improve outcomes for this patient population.
4. ‘Freezing’ Nerves May Effectively Treat Post-Mastectomy Pain in Breast Cancer Survivors
The American Cancer Society reports that approximately 20% to 30% of women with breast cancer will develop post-mastectomy pain, which could be the result of nerve damage form the surgery. Now, a new interventional radiology strategy that targets and freezes these nerves may be able to provide lasting relief, according to an expert who spoke with CURE®.
In this episode of the “Cancer Horizons” podcast, a woman shares her story of going from breast cancer advocate to patient — a role switch she never thought would happen to her, as she had no family history of breast cancer.
Stay up to date on all of the latest breast cancer news on CURE®’s breast cancer page.
For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.